Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
1.720
+0.050 (2.99%)
At close: Mar 31, 2025, 4:00 PM
1.674
-0.046 (-2.66%)
Pre-market: Apr 1, 2025, 4:06 AM EDT
Nephros Market Cap
Nephros has a market cap or net worth of $18.23 million as of April 1, 2025. Its market cap has decreased by -23.07% in one year.
Market Cap
18.23M
Enterprise Value
15.88M
1-Year Change
-23.07%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $18.23M, a decrease of -66.30%. That is a compound annual growth rate of -17.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 17.70M | 14.19% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |